Medtronic plc (NYSE: MDT) Stock Competitors & Peer Comparison
See MDT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MDT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDT | $90.65 | -0.64% | 116.1B | 16.40 | $5.53 | +3.14% |
| ABT | $110.36 | -1.88% | 190.9B | 21.18 | $5.21 | +2.24% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $323.80 | -2.08% | 124.1B | 24.18 | $13.39 | +1.08% |
| BSX | $48.30 | +3.12% | 71.8B | 15.58 | $3.10 | N/A |
| EW | $90.75 | +0.60% | 52.2B | 33.60 | $2.70 | N/A |
| DXCM | $91.06 | +0.26% | 34.4B | 35.71 | $2.55 | N/A |
| GEHC | $71.23 | -0.69% | 32.2B | 15.62 | $4.56 | +0.20% |
| PHG | $26.57 | -0.56% | 26B | 15.19 | $1.75 | +3.72% |
| ZBH | $100.04 | -0.86% | 19.3B | 11.79 | $8.48 | +0.96% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
MDT vs ABT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ABT has a market cap of 190.9B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ABT trades at $110.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ABT's P/E ratio is 21.18. In terms of profitability, MDT's ROE is +0.10%, compared to ABT's ROE of +0.11%. Regarding short-term risk, MDT is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for MDT.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
MDT vs BSX-PA Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, MDT's ROE is +0.10%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, MDT is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
MDT vs SYK Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SYK trades at $323.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SYK's P/E ratio is 24.18. In terms of profitability, MDT's ROE is +0.10%, compared to SYK's ROE of +0.16%. Regarding short-term risk, MDT is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for MDT.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
MDT vs BSX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BSX has a market cap of 71.8B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BSX trades at $48.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BSX's P/E ratio is 15.58. In terms of profitability, MDT's ROE is +0.10%, compared to BSX's ROE of +0.15%. Regarding short-term risk, MDT is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
MDT vs EW Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, EW has a market cap of 52.2B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while EW trades at $90.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas EW's P/E ratio is 33.60. In terms of profitability, MDT's ROE is +0.10%, compared to EW's ROE of +0.10%. Regarding short-term risk, MDT is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for MDT.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
MDT vs DXCM Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, DXCM has a market cap of 34.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while DXCM trades at $91.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas DXCM's P/E ratio is 35.71. In terms of profitability, MDT's ROE is +0.10%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, MDT is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for MDT.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
MDT vs GEHC Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, GEHC has a market cap of 32.2B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while GEHC trades at $71.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas GEHC's P/E ratio is 15.62. In terms of profitability, MDT's ROE is +0.10%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, MDT is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for MDT.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
MDT vs PHG Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, PHG has a market cap of 26B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while PHG trades at $26.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas PHG's P/E ratio is 15.19. In terms of profitability, MDT's ROE is +0.10%, compared to PHG's ROE of +0.10%. Regarding short-term risk, MDT is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for MDT.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
MDT vs ZBH Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ZBH trades at $100.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ZBH's P/E ratio is 11.79. In terms of profitability, MDT's ROE is +0.10%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, MDT is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for MDT.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
MDT vs ABMD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ABMD's P/E ratio is 65.36. In terms of profitability, MDT's ROE is +0.10%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, MDT is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for MDT.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
MDT vs PEN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while PEN trades at $323.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas PEN's P/E ratio is 84.38. In terms of profitability, MDT's ROE is +0.10%, compared to PEN's ROE of +0.11%. Regarding short-term risk, MDT is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for MDT.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
MDT vs SWAV Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SWAV's P/E ratio is 78.76. In terms of profitability, MDT's ROE is +0.10%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, MDT is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for MDT.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
MDT vs SNN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SNN has a market cap of 12.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SNN trades at $28.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SNN's P/E ratio is 13.53. In terms of profitability, MDT's ROE is +0.10%, compared to SNN's ROE of +0.12%. Regarding short-term risk, MDT is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for MDT.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
MDT vs ALGN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ALGN trades at $159.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ALGN's P/E ratio is 14.57. In terms of profitability, MDT's ROE is +0.10%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, MDT is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for MDT.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
MDT vs GMED Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, GMED has a market cap of 11B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while GMED trades at $81.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas GMED's P/E ratio is 18.33. In terms of profitability, MDT's ROE is +0.10%, compared to GMED's ROE of +0.12%. Regarding short-term risk, MDT is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for MDT.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
MDT vs GKOS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while GKOS trades at $179.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas GKOS's P/E ratio is -208.91. In terms of profitability, MDT's ROE is +0.10%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, MDT is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for MDT.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
MDT vs BIO-B Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BIO-B has a market cap of 10.6B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BIO-B trades at $387.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BIO-B's P/E ratio is -68.15. In terms of profitability, MDT's ROE is +0.10%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, MDT is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for MDT.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
MDT vs BIO Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BIO trades at $386.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BIO's P/E ratio is 41.66. In terms of profitability, MDT's ROE is +0.10%, compared to BIO's ROE of +0.03%. Regarding short-term risk, MDT is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
MDT vs PODD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, PODD has a market cap of 10.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while PODD trades at $148.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas PODD's P/E ratio is 25.33. In terms of profitability, MDT's ROE is +0.10%, compared to PODD's ROE of +0.27%. Regarding short-term risk, MDT is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
MDT vs MASI Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas MASI's P/E ratio is 44.43. In terms of profitability, MDT's ROE is +0.10%, compared to MASI's ROE of +0.09%. Regarding short-term risk, MDT is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for MDT.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
MDT vs BRKR Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BRKR trades at $58.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BRKR's P/E ratio is 29.15. In terms of profitability, MDT's ROE is +0.10%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, MDT is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
MDT vs BRKRP Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BRKRP trades at $428.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BRKRP's P/E ratio is 232.61. In terms of profitability, MDT's ROE is +0.10%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, MDT is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
MDT vs HAE Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while HAE trades at $103.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas HAE's P/E ratio is 20.57. In terms of profitability, MDT's ROE is +0.10%, compared to HAE's ROE of +0.11%. Regarding short-term risk, MDT is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for MDT.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
MDT vs NARI Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas NARI's P/E ratio is -59.24. In terms of profitability, MDT's ROE is +0.10%, compared to NARI's ROE of -0.00%. Regarding short-term risk, MDT is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for MDT.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
MDT vs LIVN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while LIVN trades at $79.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas LIVN's P/E ratio is 18.96. In terms of profitability, MDT's ROE is +0.10%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, MDT is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for MDT.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
MDT vs ITGR Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ITGR trades at $125.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ITGR's P/E ratio is 19.73. In terms of profitability, MDT's ROE is +0.10%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, MDT is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for MDT.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
MDT vs IRTC Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, IRTC has a market cap of 3.9B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while IRTC trades at $118.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas IRTC's P/E ratio is -276.60. In terms of profitability, MDT's ROE is +0.10%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, MDT is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for MDT.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
MDT vs AXNX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas AXNX's P/E ratio is -709.80. In terms of profitability, MDT's ROE is +0.10%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, MDT is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for MDT.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
MDT vs TMDX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while TMDX trades at $84.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas TMDX's P/E ratio is 43.08. In terms of profitability, MDT's ROE is +0.10%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, MDT is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for MDT.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
MDT vs AXGN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, AXGN has a market cap of 2.7B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while AXGN trades at $50.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas AXGN's P/E ratio is 133.58. In terms of profitability, MDT's ROE is +0.10%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, MDT is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for MDT.Check AXGN's competition here
Neogen Corporation (NASDAQ: NEOG)
MDT vs NEOG Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, NEOG has a market cap of 2.5B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while NEOG trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas NEOG's P/E ratio is 41.29. In terms of profitability, MDT's ROE is +0.10%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, MDT is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for MDT.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
MDT vs UFPT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while UFPT trades at $297.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas UFPT's P/E ratio is 30.43. In terms of profitability, MDT's ROE is +0.10%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, MDT is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for MDT.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
MDT vs BFLY Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BFLY has a market cap of 2.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BFLY trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BFLY's P/E ratio is -32.83. In terms of profitability, MDT's ROE is +0.10%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, MDT is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
MDT vs NUVA Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas NUVA's P/E ratio is 75.00. In terms of profitability, MDT's ROE is +0.10%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, MDT is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for MDT.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
MDT vs NVCR Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while NVCR trades at $17.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas NVCR's P/E ratio is -13.58. In terms of profitability, MDT's ROE is +0.10%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, MDT is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for MDT.Check NVCR's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
MDT vs ESTA Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ESTA trades at $69.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ESTA's P/E ratio is -55.02. In terms of profitability, MDT's ROE is +0.10%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, MDT is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for MDT.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
MDT vs INSP Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while INSP trades at $62.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas INSP's P/E ratio is 27.75. In terms of profitability, MDT's ROE is +0.10%, compared to INSP's ROE of +0.18%. Regarding short-term risk, MDT is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for MDT.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
MDT vs TNDM Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while TNDM trades at $22.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas TNDM's P/E ratio is -23.67. In terms of profitability, MDT's ROE is +0.10%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, MDT is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for MDT.Check TNDM's competition here
CONMED Corporation (NYSE: CNMD)
MDT vs CNMD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CNMD trades at $49.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CNMD's P/E ratio is 10.95. In terms of profitability, MDT's ROE is +0.10%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, MDT is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
MDT vs ATEC Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ATEC trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ATEC's P/E ratio is -156.17. In terms of profitability, MDT's ROE is +0.10%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, MDT is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for MDT.Check ATEC's competition here
Enovis Corporation (NYSE: ENOV)
MDT vs ENOV Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ENOV has a market cap of 1.4B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ENOV trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ENOV's P/E ratio is 7.05. In terms of profitability, MDT's ROE is +0.10%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, MDT is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for MDT.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
MDT vs IART Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while IART trades at $16.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas IART's P/E ratio is 7.17. In terms of profitability, MDT's ROE is +0.10%, compared to IART's ROE of -0.01%. Regarding short-term risk, MDT is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for MDT.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
MDT vs AORT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while AORT trades at $26.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas AORT's P/E ratio is 44.97. In terms of profitability, MDT's ROE is +0.10%, compared to AORT's ROE of -0.01%. Regarding short-term risk, MDT is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for MDT.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
MDT vs HSKA Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas HSKA's P/E ratio is -62.49. In terms of profitability, MDT's ROE is +0.10%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, MDT is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for MDT.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
MDT vs PRCT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while PRCT trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas PRCT's P/E ratio is -10.93. In terms of profitability, MDT's ROE is +0.10%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, MDT is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for MDT.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
MDT vs AVNS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas AVNS's P/E ratio is 27.77. In terms of profitability, MDT's ROE is +0.10%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, MDT is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for MDT.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
MDT vs LMRI Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while LMRI trades at $11.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas LMRI's P/E ratio is -22.71. In terms of profitability, MDT's ROE is +0.10%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, MDT is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for MDT.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
MDT vs SILK Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SILK's P/E ratio is -18.96. In terms of profitability, MDT's ROE is +0.10%, compared to SILK's ROE of -0.35%. Regarding short-term risk, MDT is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for MDT.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
MDT vs IRMD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while IRMD trades at $86.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas IRMD's P/E ratio is 43.41. In terms of profitability, MDT's ROE is +0.10%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, MDT is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
MDT vs FNA Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas FNA's P/E ratio is -19.83. In terms of profitability, MDT's ROE is +0.10%, compared to FNA's ROE of -0.35%. Regarding short-term risk, MDT is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for MDT.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
MDT vs BVS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BVS has a market cap of 924.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BVS trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BVS's P/E ratio is 17.96. In terms of profitability, MDT's ROE is +0.10%, compared to BVS's ROE of +0.28%. Regarding short-term risk, MDT is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
MDT vs CBLL Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CBLL has a market cap of 909.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CBLL trades at $23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CBLL's P/E ratio is -13.62. In terms of profitability, MDT's ROE is +0.10%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, MDT is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
MDT vs BBNX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BBNX has a market cap of 897.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BBNX trades at $19.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BBNX's P/E ratio is -12.09. In terms of profitability, MDT's ROE is +0.10%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, MDT is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BBNX's competition here
InMode Ltd. (NASDAQ: INMD)
MDT vs INMD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, INMD has a market cap of 859.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while INMD trades at $14.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas INMD's P/E ratio is 10.39. In terms of profitability, MDT's ROE is +0.10%, compared to INMD's ROE of +0.12%. Regarding short-term risk, MDT is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
MDT vs CSII Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CSII's P/E ratio is -20.83. In terms of profitability, MDT's ROE is +0.10%, compared to CSII's ROE of -0.14%. Regarding short-term risk, MDT is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for MDT.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
MDT vs SIBN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SIBN has a market cap of 843.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SIBN trades at $19.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SIBN's P/E ratio is -55.94. In terms of profitability, MDT's ROE is +0.10%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, MDT is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for MDT.Check SIBN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
MDT vs AVR Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, AVR has a market cap of 837.2M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while AVR trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas AVR's P/E ratio is -4.44. In terms of profitability, MDT's ROE is +0.10%, compared to AVR's ROE of -0.78%. Regarding short-term risk, MDT is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for MDT.Check AVR's competition here
Varex Imaging Corporation (NASDAQ: VREX)
MDT vs VREX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, VREX has a market cap of 778.4M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while VREX trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas VREX's P/E ratio is 19.46. In terms of profitability, MDT's ROE is +0.10%, compared to VREX's ROE of +0.05%. Regarding short-term risk, MDT is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for MDT.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
MDT vs AHCO Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, AHCO has a market cap of 760.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while AHCO trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas AHCO's P/E ratio is 11.41. In terms of profitability, MDT's ROE is +0.10%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, MDT is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for MDT.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
MDT vs SSII Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SSII has a market cap of 682.4M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SSII trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SSII's P/E ratio is -66.51. In terms of profitability, MDT's ROE is +0.10%, compared to SSII's ROE of -0.27%. Regarding short-term risk, MDT is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for MDT.Check SSII's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
MDT vs CTKB Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CTKB has a market cap of 617.3M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CTKB trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CTKB's P/E ratio is -25.32. In terms of profitability, MDT's ROE is +0.10%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, MDT is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
MDT vs SRDX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SRDX's P/E ratio is -34.66. In terms of profitability, MDT's ROE is +0.10%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, MDT is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for MDT.Check SRDX's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
MDT vs KIDS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, KIDS has a market cap of 598.7M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while KIDS trades at $23.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas KIDS's P/E ratio is -19.75. In terms of profitability, MDT's ROE is +0.10%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, MDT is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for MDT.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
MDT vs APEN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas APEN's P/E ratio is -9.43. In terms of profitability, MDT's ROE is +0.10%, compared to APEN's ROE of -0.85%. Regarding short-term risk, MDT is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for MDT.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
MDT vs DCTH Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, DCTH has a market cap of 568.2M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while DCTH trades at $16.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas DCTH's P/E ratio is 1646.00. In terms of profitability, MDT's ROE is +0.10%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, MDT is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for MDT.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
MDT vs ZIMV Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, MDT's ROE is +0.10%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, MDT is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for MDT.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
MDT vs CERS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CERS has a market cap of 532M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CERS trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CERS's P/E ratio is -52.69. In terms of profitability, MDT's ROE is +0.10%, compared to CERS's ROE of -0.10%. Regarding short-term risk, MDT is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CERS's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
MDT vs TCMD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, TCMD has a market cap of 518.3M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while TCMD trades at $22.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas TCMD's P/E ratio is 21.28. In terms of profitability, MDT's ROE is +0.10%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, MDT is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
MDT vs NPCE Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, NPCE has a market cap of 499.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while NPCE trades at $14.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas NPCE's P/E ratio is -25.70. In terms of profitability, MDT's ROE is +0.10%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, MDT is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for MDT.Check NPCE's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
MDT vs SGHT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SGHT has a market cap of 462.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SGHT trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SGHT's P/E ratio is -15.18. In terms of profitability, MDT's ROE is +0.10%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, MDT is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for MDT.Check SGHT's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
MDT vs CLPT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CLPT has a market cap of 454M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CLPT trades at $15.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CLPT's P/E ratio is -12.83. In terms of profitability, MDT's ROE is +0.10%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, MDT is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CLPT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
MDT vs CARL Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CARL has a market cap of 442.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CARL trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CARL's P/E ratio is -11.39. In terms of profitability, MDT's ROE is +0.10%, compared to CARL's ROE of -0.38%. Regarding short-term risk, MDT is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
MDT vs PACB Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, PACB has a market cap of 420.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while PACB trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas PACB's P/E ratio is -3.30. In terms of profitability, MDT's ROE is +0.10%, compared to PACB's ROE of -49.62%. Regarding short-term risk, MDT is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for MDT.Check PACB's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
MDT vs SENS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SENS has a market cap of 385.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SENS trades at $9.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SENS's P/E ratio is -4.14. In terms of profitability, MDT's ROE is +0.10%, compared to SENS's ROE of -1.66%. Regarding short-term risk, MDT is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for MDT.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
MDT vs OFIX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, OFIX has a market cap of 379.6M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while OFIX trades at $9.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas OFIX's P/E ratio is -6.12. In terms of profitability, MDT's ROE is +0.10%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, MDT is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for MDT.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
MDT vs CATX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CATX has a market cap of 359.2M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CATX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CATX's P/E ratio is -2.37. In terms of profitability, MDT's ROE is +0.10%, compared to CATX's ROE of -0.42%. Regarding short-term risk, MDT is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
MDT vs SMLR Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas SMLR's P/E ratio is 3.92. In terms of profitability, MDT's ROE is +0.10%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, MDT is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for MDT.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
MDT vs TMCI Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, TMCI has a market cap of 304.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while TMCI trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas TMCI's P/E ratio is -5.00. In terms of profitability, MDT's ROE is +0.10%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, MDT is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for MDT.Check TMCI's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
MDT vs TLSI Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, TLSI has a market cap of 304.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while TLSI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas TLSI's P/E ratio is -2.95. In terms of profitability, MDT's ROE is +0.10%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, MDT is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for MDT.Check TLSI's competition here
RxSight, Inc. (NASDAQ: RXST)
MDT vs RXST Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, RXST has a market cap of 303.4M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while RXST trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas RXST's P/E ratio is -6.49. In terms of profitability, MDT's ROE is +0.10%, compared to RXST's ROE of -0.17%. Regarding short-term risk, MDT is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for MDT.Check RXST's competition here
CapsoVision, Inc. (NASDAQ: CV)
MDT vs CV Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, CV has a market cap of 291.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while CV trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas CV's P/E ratio is -2.34. In terms of profitability, MDT's ROE is +0.10%, compared to CV's ROE of -1.78%. Regarding short-term risk, MDT is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for MDT.Check CV's competition here
Avita Medical Inc. (NASDAQ: RCEL)
MDT vs RCEL Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, RCEL has a market cap of 250.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while RCEL trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas RCEL's P/E ratio is -7.01. In terms of profitability, MDT's ROE is +0.10%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, MDT is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for MDT.Check RCEL's competition here
Profound Medical Corp. (NASDAQ: PROF)
MDT vs PROF Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, PROF has a market cap of 247.1M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while PROF trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas PROF's P/E ratio is -6.94. In terms of profitability, MDT's ROE is +0.10%, compared to PROF's ROE of -0.56%. Regarding short-term risk, MDT is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for MDT.Check PROF's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
MDT vs INFU Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, INFU has a market cap of 244.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while INFU trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas INFU's P/E ratio is 29.59. In terms of profitability, MDT's ROE is +0.10%, compared to INFU's ROE of +0.15%. Regarding short-term risk, MDT is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for MDT.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
MDT vs MGRM Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas MGRM's P/E ratio is -12.00. In terms of profitability, MDT's ROE is +0.10%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, MDT is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for MDT.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
MDT vs ELMD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ELMD has a market cap of 231.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ELMD trades at $27.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ELMD's P/E ratio is 21.38. In terms of profitability, MDT's ROE is +0.10%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, MDT is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
MDT vs NVRO Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas NVRO's P/E ratio is -1.91. In terms of profitability, MDT's ROE is +0.10%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, MDT is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for MDT.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
MDT vs STIM Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, STIM has a market cap of 197.6M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while STIM trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas STIM's P/E ratio is -6.45. In terms of profitability, MDT's ROE is +0.10%, compared to STIM's ROE of -1.51%. Regarding short-term risk, MDT is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for MDT.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
MDT vs BSGM Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas BSGM's P/E ratio is -5.81. In terms of profitability, MDT's ROE is +0.10%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, MDT is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for MDT.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
MDT vs LUCD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, LUCD has a market cap of 186.7M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while LUCD trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas LUCD's P/E ratio is -2.64. In terms of profitability, MDT's ROE is +0.10%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, MDT is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for MDT.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
MDT vs MDGS Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas MDGS's P/E ratio is -0.27. In terms of profitability, MDT's ROE is +0.10%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, MDT is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for MDT.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
MDT vs QIPT Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas QIPT's P/E ratio is -15.87. In terms of profitability, MDT's ROE is +0.10%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, MDT is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for MDT.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
MDT vs FOCL Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, FOCL has a market cap of 160M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while FOCL trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas FOCL's P/E ratio is -4.13. In terms of profitability, MDT's ROE is +0.10%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, MDT is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for MDT.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
MDT vs QSI Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, QSI has a market cap of 151.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while QSI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas QSI's P/E ratio is -1.66. In terms of profitability, MDT's ROE is +0.10%, compared to QSI's ROE of -0.47%. Regarding short-term risk, MDT is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for MDT.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
MDT vs INGN Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, INGN has a market cap of 145.4M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while INGN trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas INGN's P/E ratio is -5.90. In terms of profitability, MDT's ROE is +0.10%, compared to INGN's ROE of -0.13%. Regarding short-term risk, MDT is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for MDT.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
MDT vs QTRX Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, QTRX has a market cap of 125.8M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while QTRX trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas QTRX's P/E ratio is -1.05. In terms of profitability, MDT's ROE is +0.10%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, MDT is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for MDT.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
MDT vs ICAD Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas ICAD's P/E ratio is -20.37. In terms of profitability, MDT's ROE is +0.10%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, MDT is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for MDT.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
MDT vs LNSR Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, LNSR has a market cap of 103M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while LNSR trades at $8.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas LNSR's P/E ratio is 8.56. In terms of profitability, MDT's ROE is +0.10%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, MDT is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for MDT.Check LNSR's competition here
Pulmonx Corporation (NASDAQ: LUNG)
MDT vs LUNG Comparison September 2026
Medtronic plc (NYSE: MDT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDT stands at 116.1B. In comparison, LUNG has a market cap of 100.5M. Regarding current trading prices, MDT is priced at $90.65 on the NYSE, while LUNG trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDT currently has a P/E ratio of 16.40, whereas LUNG's P/E ratio is -2.05. In terms of profitability, MDT's ROE is +0.10%, compared to LUNG's ROE of -0.97%. Regarding short-term risk, MDT is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for MDT.Check LUNG's competition here